Articles about Sean McClain

AI is boosting drug discovery and development — and sparking questions about proprietary data

The culture of collaboration in the Pacific Northwest, the impact of AI on biopharma, and the shape of new business… Read More

How AI is changing the way scientists engineer drugs, biosensors, enzymes and more

Inside the headquarters of Outpace Bio in Seattle, senior scientist Bobby Langan shows a video of one of his favorite… Read More

Publicly traded biotech company Absci lays off employees, citing ‘macro-economic conditions’

Vancouver, Wash.-based drug design and development company Absci laid off employees Tuesday, a little more than a year after going… Read More

Biotech company Absci, which recently went public, cuts ribbon on new HQ in Vancouver, Wash.

Absci cut the ribbon on its new headquarters in Vancouver, Wash., on Tuesday, barely three months after going public in… Read More

Absci shares spike 30% in IPO debut, valuing Washington state biotech company at nearly $2B

Shares of Absci surged more than 30% on Thursday as the Vancouver, Wash.-based biotech company made its debut as a… Read More

Vancouver, Wash. biotech company Absci files to go public

Absci, a Vancouver, Wash.-based company developing technologies to accelerate the process of drug discovery, announced today that it plans to… Read More